What's coming to Contemporary OB/GYN this week?
The rate of unintended pregnancies throughout the US military declined significantly since 2005, according to a study published in Contraception.1 Nevertheless, authors say, the burden that such pregnancies place on female servicemembers and the military health care system continues to demand aggressive upfront education and counseling.
After the Antenatal Late Preterm Steroid (ALPS) trial showed a decrease in respiratory complications following steroid administration, steroid exposure among newborns increased.
While access to prenatal care did increase in states after Medicaid expansion, disparities persisted and even increased among Asian and Hispanic immigrant pregnant women, according to an analysis in JAMA Network Open.
Low-molecular-weight heparin (LMWH) did not increase the live-birth rate in comparison to standard therapy for pregnant women.
Research suggests that combined hormonal contraceptives (CHC) have a similar safety profile to progestin-only contraceptives (POC) with regard to women with sickle cell disease and their risk of thromboembolism (TE).
Adaptability and flexibility will be needed to deal with for challenges next year.
This month, the US Centers for Medicare & Medicaid Services (CMS) announced the draft rule with five key provisions and five requests for information. If implement, CMS estimated the changes would save physicians and hospitals more than $15 billion over 10 years.
Check back soon for additional updates!
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More